A randomized phase II trial of ATN-224 in combination with temozolomide or temozolomide followed by ATN-224 in patients with advanced melanoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2007
At a glance
- Drugs Bis-choline tetrathiomolybdate (Primary) ; Temozolomide
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Attenuon
- 20 Dec 2007 Status changed from recruiting to in progress.
- 23 Jul 2007 New trial record.